Health Supplements Market Summary
As per Market Research Future Analysis, the Global Health Supplements Market was valued at USD 7.5 billion in 2022 and is projected to reach USD 16.42 billion by 2032, growing at a CAGR of 9.10% from 2023 to 2032. Key drivers include increased urbanization, a shift towards preventative healthcare, and heightened consumer focus on health and immunity. The market is witnessing a surge in demand for vitamins, minerals, and organic products, driven by changing dietary habits and an aging population. Regulatory initiatives are also shaping the market landscape, with increased scrutiny on product claims and labeling. Notable product launches, such as Oriflame India's new supplements and TrueNorth's 'Sensibiotics,' reflect the industry's innovation in response to consumer needs.
Key Market Trends & Highlights
The market is experiencing significant growth driven by health awareness and innovation.
- Health Supplements Market Size in 2022: USD 7.5 billion; projected to reach USD 16.42 billion by 2032.
- CAGR from 2023 to 2032: 9.10%; driven by urbanization and preventative healthcare.
- India's nutraceutical market value reached USD 5404.18 million in 2022; expected CAGR of 11.77% up to 2032.
- North America is the largest market due to strong consumer buying power and health trends.
Market Size & Forecast
2022 Market Size | USD 7.5 Billion |
2032 Market Size | USD 16.42 Billion |
CAGR (2023-2032) | 9.10% |
India's nutraceutical market value in 2022 | USD 2032.18 million |
Major Players
Herbalife International (U.S.), BASF SE (Germany), E. I. du Pont de Nemours and Company (U.S.), Glanbia plc (Republic of Ireland), Abbott Laboratories (U.S.), Alticor Inc. (U.S.), The Nature's Bounty Co. (U.S.), Bayer AG (Germany), GlaxoSmithKline Limited (U.K.)